Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 99.28% is in line with its 5-year average of 97.92%, near the high end of its 5-year range (0.00%–100.00%).
66.05% above its 12-month average of 59.79%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
99.28%
GROSS MARGIN AVG TTM
59.79%
GROSS MARGIN AVG 3Y
98.81%
GROSS MARGIN AVG 5Y
97.92%
GROSS MARGIN AVG 10Y
96.35%
GROSS MARGIN AVG 15Y
96.58%
GROSS MARGIN AVG 20Y
97.28%
CURRENT VS TTM AVG
+66.05%
CURRENT VS 3Y AVG
+0.48%
CURRENT VS 5Y AVG
+1.39%
CURRENT VS 10Y AVG
+3.04%
CURRENT VS 15Y AVG
+2.79%
CURRENT VS 20Y AVG
+2.05%
SECTOR MEDIAN · HEALTHCARE
41.03%
median of 851 covered companies
CURRENT VS SECTOR MEDIAN
+141.97%
vs the sector median at left
Market Cap
$1.47M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.47M
Gross Margin
10.31%
TTM Avg
42.76%
3Y Avg
35.97%
5Y Avg
38.88%
Market Cap
$1.43M
Gross Margin
88.34%
TTM Avg
40.30%
3Y Avg
45.15%
5Y Avg
63.43%
Market Cap
$1.43M
Gross Margin
33.34%
TTM Avg
40.48%
3Y Avg
28.36%
5Y Avg
50.23%
Market Cap
$1.36M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Curis, Inc. (CRIS) | $1.42M | 99.28% | 59.79% | 98.81% | 97.92% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.47M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | 10.31% | 42.76% | 35.97% | 38.88% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.43M | 88.34% | 40.30% | 45.15% | 63.43% |
| INVO Fertility, Inc. (IVF)vs › | $1.43M | 33.34% | 40.48% | 28.36% | 50.23% |
| NEXGEL, Inc. (NXGL)vs › | $1.44M | 35.07% | 35.55% | 23.19% | 8.35% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.35M | 0.00% | 0.00% | 0.00% | 0.00% |
| NewcelX Ltd. (NCEL)vs › | $1.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| Silo Pharma, Inc. (SILO)vs › | $1.60M | -1128.89% | -518.50% | -213.30% | -126.70% |
Gross Margin
99.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 99.53% |
| 2025-06-30 | 99.42% |
| 2025-03-31 | 99.41% |
| 2024-12-31 | 99.49% |
| 2024-09-30 | 99.25% |
| 2024-06-30 | 99.53% |
| 2024-03-31 | 97.75% |
| 2023-12-31 | 98.00% |
| 2023-09-30 | 97.88% |
| 2023-06-30 | 96.63% |
| 2023-03-31 | 98.96% |
| 2022-12-31 | 97.54% |
| 2022-09-30 | 97.81% |
| 2022-06-30 | 98.24% |
| 2022-03-31 | 96.01% |
| 2021-12-31 | 94.99% |
| 2021-09-30 | 95.03% |
| 2021-06-30 | 94.93% |
| 2021-03-31 | 95.02% |
| 2020-12-31 | 95.01% |
| 2020-09-30 | 95.08% |
| 2020-06-30 | 94.83% |
| 2020-03-31 | 95.39% |
| 2019-12-31 | 95.10% |
| 2019-09-30 | 94.92% |
| 2019-06-30 | 95.75% |
| 2019-03-31 | 93.89% |
| 2018-12-31 | 94.70% |
| 2018-09-30 | 94.59% |
| 2018-06-30 | 94.32% |
| 2018-03-31 | 94.77% |
| 2017-12-31 | 94.94% |
| 2017-09-30 | 94.93% |
| 2017-06-30 | 95.34% |
| 2017-03-31 | 94.79% |
| 2016-12-31 | 94.88% |
| 2016-09-30 | 94.66% |
| 2016-06-30 | 94.35% |
| 2016-03-31 | 94.86% |
| 2015-12-31 | 95.10% |
| 2015-09-30 | 94.32% |
| 2015-06-30 | 95.06% |
| 2015-03-31 | 94.93% |
| 2014-12-31 | 95.32% |
| 2014-09-30 | 94.94% |
| 2014-06-30 | 98.09% |
| 2014-03-31 | 94.93% |
| 2013-12-31 | 95.39% |
| 2013-09-30 | 99.25% |
| 2013-06-30 | 99.25% |
| 2013-03-31 | 96.19% |
| 2012-12-31 | 98.34% |
| 2012-09-30 | 96.14% |
| 2012-06-30 | 99.71% |
| 2012-03-31 | 98.90% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.05% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 60.19% |
| 2006-09-30 | 92.32% |
| 2006-06-30 | 82.41% |
| 2006-03-31 | 71.16% |
| 2005-12-31 | -3.29% |
| 2005-09-30 | 98.97% |
| 2005-06-30 | 98.77% |
| 2005-03-31 | -19.22% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 98.74% |
| 2004-06-30 | 98.32% |
| 2004-03-31 | 97.81% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 99.80% |
| 2003-06-30 | 96.58% |
| 2003-03-31 | 95.69% |
| 2002-12-31 | 70.05% |
| 2002-09-30 | 72.97% |
